Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Mount Sinai South Nassau"


3 mentions found


Can Vending Machines Help Curb STDs?
  + stars: | 2024-02-07 | by ( Steven Ross Johnson | Feb. | At P.M. | ) www.usnews.com   time to read: +5 min
Vending machines offering tests for sexually transmitted infections hold promise as a way to reach people with sexual health services, according to a study that comes on the heels of recent increases in STIs in both the U.S. and England. For the study, published in the journal Sexually Transmitted Infections, researchers analyzed data associated with nearly a dozen vending machines in two regions of England that were stocked with free kits to help detect chlamydia, gonorrhea, syphilis and HIV. Approximately 6% of the STI tests were positive for chlamydia, while 2.5% tested positive for gonorrhea, according to the study. A total of four samples tested positive for HIV, though they were from people already known to be HIV positive, and three tests came back positive for syphilis antibodies. Previous research suggests vending machines that offer self-tests for HIV can lead to increased uptake in testing among men who have sex with men, and the latest study adds to those findings.
Persons: , what’s, , Aaron Glatt, Glatt Organizations: U.S, World Health Organization, The Washington Post, Department of Medicine, Infectious Diseases Society of America Locations: STIs, England, Black, U.S, Mount Sinai South Nassau, New York
The methods for counting COVID deaths have varied across countries in the nearly three years since the pandemic began. CAN CHINA'S COVID DATA BE TRUSTED? With one of the lowest COVID death tolls in the world, China has been routinely accused of downplaying infections and deaths for political reasons. Globally, the study estimated 18.2 million excess deaths in 2021-2022, compared with reported COVID deaths of 5.94 million. China actually cut its accumulated death toll by one on Dec. 20, bringing the total to 5,241.
New RSV vaccines may soon put an end to rough seasons
  + stars: | 2022-10-31 | by ( Brenda Goodman | ) edition.cnn.com   time to read: +15 min
The monoclonal antibody, Synagis, is given monthly during RSV season to protect preemies and other high-risk babies. In the failed RSV vaccine trial, the chemical the researchers used to deactivate the virus denatured its proteins – essentially flattening them. Four companies have RSV vaccines for adults in the final phases of human trials: Pfizer and GSK are testing vaccines for pregnant women as well as seniors. Janssen, Pfizer and GSK each appear effective at preventing infections in adults for the first RSV season after the vaccine. The vaccines for pregnant women are meant to get newborns through their first RSV season.
Total: 3